In a pathologic condition such as metabolic syndrome, FGF21 increase to compensate for oxidative stress, ER stress, and mitochondrial dysfunction; thus, higher serum levels reflect uncompensated metabolic stress (12). This evidence concerns the gene FGF21 and metabolic syndrome.